SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8.72 |
Enterprise Value ($M) | -1.16 |
Book Value ($M) | 31.99 |
Book Value / Share | 1.27 |
Price / Book | 0.27 |
NCAV ($M) | 29.40 |
NCAV / Share | 1.17 |
Price / NCAV | 0.30 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.82 |
Return on Assets (ROA) | -0.44 |
Return on Equity (ROE) | -0.50 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.82 |
Current Ratio | 6.82 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 35.68 |
Assets | 38.27 |
Liabilities | 6.29 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -31.66 |
Net Income | -30.16 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -24.67 |
Cash from Investing | 22.44 |
Cash from Financing | -0.79 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
6,034 | 234,870 | 2.57 | |
18,944 | 242,106 | 7.82 | |
24,377 | 129,964 | 18.76 | |
19,542 | 127,375 | 15.34 | |
(click for more detail) |
Similar Companies | |
---|---|
SNDL – SNDL Inc. | SNGX – Soligenix, Inc. |
SNPX – Synaptogenix, Inc. | SNTI – Senti Biosciences, Inc. |
SNYR – Synergy CHC Corp. |
Financial data and stock pages provided by
Fintel.io